A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...
The experiment might send shivers down your spine and naturally raise ethical concerns, yet researchers have boldly described these studies as a step forward in ...
Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...
Zacks Small Cap Research on MSN

DYAI: Layers of commercialization agreements

The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...
Researchers have used CRISPR to switch back on a gene that vanished from the human lineage roughly 20 million years ago, ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...
Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...
Introduction: Human butyrylcholinesterase (hBChE) is a promising bioscavenger against organophosphorus (OP) nerve agents and pesticides. However, low homology-directed repair (HDR) efficiency in ...
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...